Literature DB >> 9927751

3'-Terminal RNA structures and poly(U) tracts inhibit initiation by a 3'-->5' exonuclease in vitro.

L P Ford1, J Wilusz.   

Abstract

We have previously shown that the presence of a poly(A) tail blocks the activity of a highly efficient 3'-->5' exonuclease in HeLa extracts. Similar activities have been implicated in RNA turnover in vivo. It is not clear, however, what protects poly(A)-non-mRNAs from the action of this enzyme. A stem-loop structure located at the 3'-end of U11 RNA was required to protect this transcript from the exonuclease in vitro. Similar 3' stem-loop structures, or extensive base pairinginvolving the 3'-end, are present on all mature small stable RNAs. The placement of artificial stem-loop structures at the 3'-end also protected RNA substrates, suggesting that RNA structure alone is sufficient to block the initiation of the exonuclease. The placement of RNA structures at internal positions of substrate trans-cripts did not affect the activity of the exonuclease or lead to the accumulation of degradation intermediates. Pol III precursor transcripts contain short poly(U) tracts rather than structure at their 3'-ends. Terminal poly(U) tracts protected RNA substrates from the 3'-->5' exonuclease in a protein-dependent fashion. Although La protein is found associated with the terminal U tracts of pol III precursor transcripts both in vivo and in vitro, La protein was not required for poly(U) to protect RNA substrates from the 3'-->5' exonuclease. In summary, these data reveal a variety of ways RNAs have evolved to protect themselves from this exonuclease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927751      PMCID: PMC148298          DOI: 10.1093/nar/27.4.1159

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  Effect of 3' terminal adenylic acid residue on the uridylation of human small RNAs in vitro and in frog oocytes.

Authors:  Y Chen; K Sinha; K Perumal; R Reddy
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 2.  Inhibition and avoidance of mRNA degradation by RNA viruses.

Authors:  Stephanie L Moon; Michael D Barnhart; Jeffrey Wilusz
Journal:  Curr Opin Microbiol       Date:  2012-05-23       Impact factor: 7.934

Review 3.  New ways to meet your (3') end oligouridylation as a step on the path to destruction.

Authors:  Carol J Wilusz; Jeffrey Wilusz
Journal:  Genes Dev       Date:  2008-01-01       Impact factor: 11.361

Review 4.  RNA recognition by 3'-to-5' exonucleases: the substrate perspective.

Authors:  Hend Ibrahim; Jeffrey Wilusz; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2007-12-03

5.  Poly(A)-binding-protein-mediated regulation of hDcp2 decapping in vitro.

Authors:  Richie Khanna; Megerditch Kiledjian
Journal:  EMBO J       Date:  2004-04-15       Impact factor: 11.598

6.  Sla1, a Schizosaccharomyces pombe homolog of the human La protein, induces ectopic meiosis when its C terminus is truncated.

Authors:  Kaori Tanabe; Noriko Ito; Tomomi Wakuri; Fumiyo Ozoe; Makoto Umeda; Satoshi Katayama; Katsunori Tanaka; Hideyuki Matsuda; Makoto Kawamukai
Journal:  Eukaryot Cell       Date:  2003-12

7.  Regulated alpha-globin mRNA decay is a cytoplasmic event proceeding through 3'-to-5' exosome-dependent decapping.

Authors:  Nancy D Rodgers; Zuoren Wang; Megerditch Kiledjian
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

8.  3' Terminal oligo U-tract-mediated stimulation of decapping.

Authors:  Man-Gen Song; Megerditch Kiledjian
Journal:  RNA       Date:  2007-10-17       Impact factor: 4.942

9.  Modifications of the 3'-UTR stem-loop of infectious bursal disease virus are allowed without influencing replication or virulence.

Authors:  Hein J Boot; Sylvia B E Pritz-Verschuren
Journal:  Nucleic Acids Res       Date:  2004-01-12       Impact factor: 16.971

10.  The 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells.

Authors:  Nicole L Garneau; Kevin J Sokoloski; Mateusz Opyrchal; C Preston Neff; Carol J Wilusz; Jeffrey Wilusz
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.